https://clinicaltrials.gov/ct2/show/NCT04548999?type=Intr
https://clinicaltrials.gov/ct2/show/NCT04548999?type=Intr&cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14
Condition : Multiple Sclerosis
Interventions : Drug: Ocrelizumab; Drug: Antihistamine; Drug: Methylprednisolone
Sponsor : Hoffmann-La Roche
Not yet recruiting
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
NCT04548999
Tue, 15 Sep 2020 12:00:00 EDT
First Added: 09/15/20 06:49AM